- Genetic Tests
- Genetic Counseling
- SANCO prenatal test
- RHD SANCO test
- Infano test
- Parento test
- Genetic knowledge database
- Polgenom
- Certificates
- Team
- Make an appointment
- Contact
NZOZ genomed
>
Genetic testing
> Cardiomyopathy (hypertrophic and dilated)
Genetic testing
Genetic testing
Waluta
Cardiomyopathy (hypertrophic and dilated)
Cardiomyopathy (hypertrophic and dilated)
Test code: KP-ACMG-NGSNGS analysis of coding regions of 33 genes, related to sudden cardiac death (SCD) and other cardio-vascular events acc to ACMG v3.1: ACTA2, ACTC1, BAG3, CASQ2, COL3A1, DES, DSC2, DSG2, DSP, FBN1, FLNC, KCNH2, KCNQ1, LMNA, MYBPC3, MYH11, MYH7, MYL2, MYL3, PKP2, PRKAG2, RBM20, RYR2, SCN5A, TGFBR1, TGFBR2, TMEM43, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TTN
We perform genetic testing from:


Cardiomyopathy (hypertrophic and dilated)
Test code: KP-NGSPanel of 80 genes known to be associated with hypertrophic, dilated and left ventricular non-compaction, based on the Whole-Exome Sequencing (WES).
We perform genetic testing from:


Cardiomyopathy (hypertrophic and dilated)
Cardiomyopathy is a disease of the heart muscle.We distinguish between dilated cardiomyopathy, the most common primary heart muscle disease, and hypertrophic cardiomyopathy, which is characterised by hypertrophy of the heart muscle with asymmetric thickening of the interventricular septum and reduced left ventricular cavity.
There are many risk factors that increase the chance of developing dilated cardiomyopathy, but genetic factors are the most important. More than 40 genes are responsible for the diverse manifestations of non-syndromic dilated cardiomyopathy.
The phenotypic variation in hypertrophic cardiomyopathy is also explained by the involvement of different mutations in the pathogenesis of this disease, with 29 genes now known to be associated with this condition.